Last updated: December 6, 2023
Sponsor: Chinese University of Hong Kong
Overall Status: Active - Recruiting
Phase
N/A
Condition
Mild Cognitive Impairment
Memory Problems
Memory Loss
Treatment
Ageing
Clinical Study ID
NCT05728801
2019.078
Ages 60-95 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- SuperAgers are determined by the scores of global cognitive function. This ensuredthat the participants are divided by a measure relevant to the current study withoutdirectly biasing the results toward the domain of interest;
- Normal aging: the cases with the scores of cognitive performance within 1.5 standarddeviation (SD) of age and education matched normative values derived from our cohortstudy, of which presented with HK MoCA score greater than 26 and CDR score equal to 0;
- NCD patients are defined as: evidence of modest decline in one or more cognitivedomains, which is set as ≥ 1.5 SD below the age- and education-adjusted normativescores; no interference with independence in everyday activities; and no comorbidmajor psychiatric disorders.
Exclusion
Exclusion Criteria:
- History of bipolar disorders or psychosis;
- History of major neurological deficits including stroke, transient ischemic attack ortraumatic brain injury;
- Comorbidities with depressive symptoms.
Study Design
Total Participants: 400
Treatment Group(s): 1
Primary Treatment: Ageing
Phase:
Study Start date:
June 01, 2022
Estimated Completion Date:
December 01, 2024
Study Description
Connect with a study center
Tai Po Hospital
Hong Kong,
Hong KongActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.